Table 2 Cohorts used in this study.

From: Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma

Cohort name

Tumor type

Cohort size

Target checkpoint

PUCH

Melanoma

55

PD-1

Riaz17 (15)

Melanoma

51

PD-1

Gide19 (21)

Melanoma

41

PD-1

Hugo16 (14)

Melanoma

28

PD-1

VanAllen15 (40)

Melanoma

42

CTLA-4

Liu19 (13)

Melanoma

54

PD-1

Kim18 (41)

Gastric

45

PD-1

Back to article page